… -2 oral drugs (nirmatrelvir/ritonavir and molnupiravir), (iii) summarizes the clinical progress of
other oral antivirals for use in COVID-19, (iv… with the use of oral antivirals in clinical practice. …

… distributed oral antivirals are urgently needed to treat coronavirus disease-2019 (COVID-19), …
, and block transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…

… made in COVID-19 research and many antiviral drugs have … against COVID-19, a simple
oral antiviral drug for COVID-19 has … among COVID-19 patients with three new oral antivirals (…

… This review aims to summarize ongoing antiviral treatments in COVID-19, to discuss …
COVID-19) evaluating oral antiviral Favipiravir's at home use for mild-to-moderate COVID-19 …

… “The oral antivirals do not have the complications of the … be the most widely available antiviral
for COVID-19. Paxlovid is a … order of 50 000 doses of the antiviral—the interim results had …

… -based antiviral agents could be repurposed for COVID-19 treatment. … COVID-19 epidemic
and is potentially to be used to treat future coronavirus infections as well as other coronavirus-…

… Despite this breakthrough, COVID-19 will constitute an enduring public health issue [8]. …
oral alternatives [15]. In early 2021, EMA approved the first oral antiviral against COVID-19, ie, …

… for COVID-19 oral antiviral … COVID-19 oral antivirals. The emerging lessons from molnupiravar
are of interest to future design of COVID-19 theranostic research with other oral antiviral …

… —the development of oral antiviral treatment for COVID-19 still needs further study. In addition
to molnupiravir, four more oral anti-COVID-19 drugs are in phase 3 clinical trials: the 3CL …

… time from the start of treatment to having negative nasopharyngeal swabs (7 days in the
group receiving the triple therapy compared to 12 days in the control group receiving just oral …